JETEMA Co., Ltd.  ·  Republic of Korea

Kaimax 200U is the 200-unit single-vial format of JETEMA’s vacuum-dried botulinum toxin type A. Each single-use vial contains 200 units of botulinum toxin type A, reconstituted with 0.9% sterile saline before injection.

Kaimax 200U is manufactured by JETEMA Co., Ltd., a KOSDAQ-listed Korean biopharmaceutical company.

Kaimax 200U uses vacuum-drying. The vial may appear nearly empty or have only a faint dried film — this is normal vacuum-dried product appearance. The full 200 units of botulinum toxin type A are present and dissolve when reconstituted with sterile saline.

Kaimax 200U contains 200 units of botulinum toxin type A per vial; Kaimax 100U contains 100 units. Both share the same active ingredient, JETEMA proprietary working strain, and vacuum-drying process.

Both Kaimax 200U and Toxta 200U are manufactured by JETEMA Co., Ltd. using the same production platform and same proprietary working strain. They are sister products with different brand positioning.

Common aesthetic application zones include glabellar lines, forehead lines, lateral canthal lines, masseter contouring, mentalis muscle, and platysma bands. The 200U pack is particularly suited for multi-zone single-patient treatments or shared-vial multi-patient protocols.

Both are 200-unit Korean botulinum toxin type A products. Kaimax is manufactured by JETEMA using vacuum-drying. Botulax is manufactured by Hugel Pharma using freeze-drying with Hugel’s proprietary working strain.

Both are 200-unit vacuum-dried Korean botulinum toxin type A products. Kaimax is manufactured by JETEMA. Nabota is manufactured by Daewoong Pharmaceutical.

Onset and duration vary with individual anatomy, muscle mass, metabolism, treatment zone, and dosing strategy.

Store unopened vials at 2–8 °C, protected from light. Do not freeze. After reconstitution with 0.9% sterile saline, use within 24 hours when stored refrigerated.